Get the Stockscreener App
0.5158
3.32%
-0.0177
After Hours:
.51
-0.0058
-1.12%
Nkgen Biotech Inc Stock (NKGN) Forecast
The Nkgen Biotech Inc (NKGN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.3875, representing a -24.87% decrease from the current price of $0.5158. The highest analyst price target is $0.7126, and the lowest is $0.0624.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NKGN Price Target
Average 1.4276
(+176.78% Upside)
Is Nkgen Biotech Inc (NKGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.93 | Neutral |
| STOCH(9,6) | 34.83 | Neutral |
| STOCHRSI(14) | 38.26 | Neutral |
| MACD(12,26) | 0.004 | Sell |
| ADX(14) | 27.81 | Buy |
| William %R | -70.77 | Neutral |
| CCI(14) | -23.07 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5238
Sell
|
0.5337
Sell
|
| MA20 |
0.5265
Sell
|
0.5314
Sell
|
| MA50 |
0.5507
Sell
|
0.522
Sell
|
| MA100 |
0.4557
Buy
|
0.5637
Sell
|
| MA200 |
0.7423
Sell
|
0.8589
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, NKGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on NKGN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.93 indicates that NKGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.83 indicates that NKGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.26 indicates that NKGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.81 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -23.07 indicates that NKGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NKGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nkgen Biotech Inc financial reports and earnings history, Nkgen Biotech Inc (NKGN) stock could reach $13.26 by 2030, $27.08 by 2040 and $65.71 by 2050. See the projected annual prices until 2050 of the Nkgen Biotech Inc stock below:
- Nkgen Biotech Inc (NKGN) is expected to reach an average price of $20.44 in 2035, with a high prediction of $21.32 and a low estimate of $20.47. This indicates an $3,863% rise from the last recorded price of $0.5158.
- Nkgen Biotech Inc (NKGN) stock is projected to chart a bullish course in 2040, with an average price target of $23.33, representing an $4,423% surge from its current level. The forecast ranges from a conservative $23.85 to a sky-high $27.08.
- Our analysts predict Nkgen Biotech Inc (NKGN) to jump 11,380% by 2045, soaring from $25.10 to an average price of $59.22, potentially reaching $58.67. While $25.10 is the low estimate, the potential upside is significant.
- Nkgen Biotech Inc (NKGN) stock is expected to climb by 2050, reaching an average of $61.59, a $11,841% jump from its current level. However, a wide range of estimates exists, with high and low targets of $65.71 and $61.66, respectively, highlighting the market's uncertainty.
Nkgen Biotech Inc Stock (NKGN) Year by Year Forecast
Nkgen Biotech Inc Stock (NKGN) Price Forecast for 2025
Nkgen Biotech Inc Stock (NKGN) is expected to reach an average price of $1.3971 in 2025, with a high prediction of $2.7318 and a low estimate of $0.0624. This indicates an +170.86% rise from the last recorded price of $0.5158.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $0.3391 | $0.0624 | $0.7126 | -34.25% |
| May, 2025 | $1.3249 | $0.4231 | $0.5049 | +156.87% |
| June, 2025 | $1.5607 | $1.1467 | $1.0607 | +202.58% |
| July, 2025 | $0.0896 | $0.4304 | $1.6975 | -82.63% |
| August, 2025 | $0.8602 | $0.4643 | $0.7022 | +66.76% |
| September, 2025 | $2.62 | $0.348 | $0.58 | +407.95% |
| October, 2025 | $2.5746 | $2.8246 | $2.7318 | +399.14% |
| November, 2025 | $1.7783 | $2.3982 | $2.4064 | +244.77% |
| December, 2025 | $1.9828 | $1.7061 | $1.6091 | +284.41% |
Nkgen Biotech Inc Stock (NKGN) Price Forecast for 2026
The predicted value for Nkgen Biotech Inc (NKGN) in 2026 is set at an average of $2.9689. Estimates vary from a peak of $4.7058 to a trough of $1.232, indicating an +475.59% surge from the present price of $0.5158.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0793 | $1.9037 | $1.6855 | +303.11% |
| February, 2026 | $2.4401 | $2.4601 | $2.3183 | +373.07% |
| March, 2026 | $1.3638 | $2.7636 | $2.7929 | +164.40% |
| April, 2026 | $1.8483 | $1.5456 | $1.7183 | +258.34% |
| May, 2026 | $1.2806 | $1.232 | $1.3293 | +148.28% |
| June, 2026 | $4.2337 | $4.86 | $4.7058 | +720.79% |
| July, 2026 | $4.1731 | $4.3531 | $4.2604 | +709.05% |
| August, 2026 | $3.2146 | $3.3497 | $3.521 | +523.23% |
| September, 2026 | $3.2841 | $3.3941 | $3.1862 | +536.69% |
| October, 2026 | $3.7656 | $3.5518 | $3.6977 | +630.05% |
| November, 2026 | $4.0081 | $3.7735 | $4.0071 | +677.07% |
| December, 2026 | $2.8166 | $2.6287 | $2.2166 | +446.06% |
Nkgen Biotech Inc Stock (NKGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nkgen Biotech Inc (NKGN) is $5.3848, with a high forecast of $8.6537 and a low forecast of $2.116. This indicates an +943.98% increase from the last price of $0.5158.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.1581 | $2.1981 | $2.7345 | +318.40% |
| February, 2027 | $6.8797 | $2.116 | $6.6797 | +1,234% |
| March, 2027 | $6.244 | $6.314 | $6.1594 | +1,111% |
| April, 2027 | $4.9834 | $5.2386 | $5.9189 | +866.16% |
| May, 2027 | $4.9729 | $4.9929 | $4.6631 | +864.11% |
| June, 2027 | $5.2671 | $4.8726 | $5.0771 | +921.16% |
| July, 2027 | $5.4396 | $5.0869 | $5.1966 | +954.59% |
| August, 2027 | $3.256 | $3.776 | $5.2214 | +531.25% |
| September, 2027 | $3.1403 | $3.5503 | $3.7506 | +508.82% |
| October, 2027 | $9.0418 | $3.00 | $8.4968 | +1,653% |
| November, 2027 | $8.1991 | $8.4491 | $8.6537 | +1,490% |
| December, 2027 | $6.8833 | $6.9483 | $7.8328 | +1,234% |
Nkgen Biotech Inc Stock (NKGN) Price Forecast for 2028
In 2028, Nkgen Biotech Inc (NKGN) is projected to reach an average price of $7.2558, with a high projection of $10.63 and a low estimate of $3.884. This indicates an +1,307% rise from the last price of $0.5158.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.7156 | $6.637 | $6.6101 | +1,202% |
| February, 2028 | $6.4157 | $6.3511 | $6.2093 | +1,144% |
| March, 2028 | $6.6821 | $6.4002 | $6.4566 | +1,195% |
| April, 2028 | $4.9294 | $5.2194 | $6.4439 | +855.67% |
| May, 2028 | $4.7925 | $4.793 | $4.7667 | +829.14% |
| June, 2028 | $10.78 | $3.884 | $7.58 | +1,990% |
| July, 2028 | $10.43 | $10.55 | $10.63 | +1,921% |
| August, 2028 | $8.7493 | $9.3692 | $9.885 | +1,596% |
| September, 2028 | $8.5344 | $8.2807 | $8.448 | +1,555% |
| October, 2028 | $7.7196 | $7.8296 | $7.732 | +1,397% |
| November, 2028 | $7.6936 | $7.7136 | $7.836 | +1,392% |
| December, 2028 | $6.0888 | $7.4886 | $7.6912 | +1,080% |
Nkgen Biotech Inc Stock (NKGN) Price Forecast for 2029
The 2029 price forecast for Nkgen Biotech Inc Stock (NKGN) is $9.6717 on average, with a high prediction of $14.58 and a low estimate of $4.768. This represents an +1,775% increase from the previous price of $0.5158.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.9128 | $5.8752 | $5.7828 | +1,046% |
| February, 2029 | $5.0148 | $4.768 | $5.2616 | +872.24% |
| March, 2029 | $12.00 | $12.64 | $12.60 | +2,226% |
| April, 2029 | $11.67 | $11.74 | $11.88 | +2,163% |
| May, 2029 | $9.7893 | $9.9244 | $11.25 | +1,798% |
| June, 2029 | $9.3823 | $9.4923 | $9.495 | +1,719% |
| July, 2029 | $9.4054 | $9.3081 | $9.2154 | +1,723% |
| August, 2029 | $8.8653 | $8.9013 | $9.0312 | +1,619% |
| September, 2029 | $6.7674 | $6.9574 | $6.0874 | +1,212% |
| October, 2029 | $5.8262 | $5.8662 | $6.7989 | +1,030% |
| November, 2029 | $14.78 | $5.652 | $14.58 | +2,765% |
| December, 2029 | $13.66 | $13.69 | $13.79 | +2,548% |
Nkgen Biotech Inc Stock (NKGN) Price Forecast for 2030
Nkgen Biotech Inc Stock (NKGN) is expected to reach an average price of $11.54 in 2030, with a high forecast of $16.55 and a low forecast of $6.536. This signifies an +2,138% surge from the last price of $0.5158.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.69 | $12.08 | $13.26 | +2,166% |
| February, 2030 | $11.15 | $11.17 | $11.11 | +2,062% |
| March, 2030 | $11.21 | $10.78 | $10.74 | +2,074% |
| April, 2030 | $10.52 | $10.34 | $10.59 | +1,940% |
| May, 2030 | $7.7168 | $8.2368 | $10.19 | +1,396% |
| June, 2030 | $7.7418 | $7.945 | $7.815 | +1,401% |
| July, 2030 | $17.07 | $6.536 | $16.52 | +3,209% |
| August, 2030 | $15.70 | $15.95 | $16.55 | +2,944% |
| September, 2030 | $13.98 | $14.60 | $15.07 | +2,610% |
| October, 2030 | $13.03 | $13.04 | $13.58 | +2,425% |
| November, 2030 | $12.20 | $12.22 | $12.37 | +2,265% |
| December, 2030 | $11.63 | $11.65 | $11.97 | +2,155% |
3.13%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):